Latest trends in drugs of abuse - HIV infection and neuroAIDS

Future Virology

Volumn 8, Issue 2, 2013, Pages 121-127

  Tiwari, Sneham ^a   Nair, Madhavan Pn ^b   Saxena, Shailendra K ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

alcohol; cocaine; drug abuse; HIV; methamphetamine; morphine; neuroAIDS; tobacco

Indexed keywords

ALCOHOL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CANNABINOID; COCAINE; CYTOCHROME P450 2A6; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; METHAMPHETAMINE; NANOCARRIER; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL ABUSE; BLOOD BRAIN BARRIER; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONFERENCE PAPER; DRUG ABUSE; DRUG DELIVERY SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SMOKING; TOBACCO DEPENDENCE; VIRUS PATHOGENESIS;

EID: 84873929448     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.134     Document Type: Conference Paper

References (29)

1. Saxena SK, Tiwari S, Nair MPN. A global perspective on HIV/AIDS. Science 337(6096), 798 (2012).
2. Samikkannu T, Rao KV, Gandhi N et al. Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: implications for neuroAIDS. J. Neurovirol. 16(4), 255-263 (2010).
3. Molina PE, Amedee A, LeCapitaine NJ et al. Cannabinoid neuroimmune modulation of SIV disease. J. Neuroimmune Pharmacol. 6(4), 516-527 (2011).
4. Molina PE, Lang CH, McNurlan M et al. Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting. Alcohol Clin. Exp. Res. 32(1), 138-147 (2008). (Pubitemid 350293895)
5. Jin M, Earla R, Shah A et al. A LC-MS/MS method for concurrent determination of CYP2A6-mediated nicotine metabolites and analysis of nicotine-mediated oxidative stress in U937 macrophages. J. Neuroimmune Pharmacol. 7(1), 289-299 (2012).
6. Ande A, Earla R, Jin M et al. An LC-MS/ MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes. Drug Alcohol Depend. 125(1-2), 49-59 (2012).
7. Heaton RK, Clifford DB, Franklin DR et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23), 2087-2096 (2010).
8. Singh MV, Davidson DC, Kiebala M et al. Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. J. Virol. Methods 181(2), 170-176 (2012).
9. Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9(1), 61-67 (2003). (Pubitemid 36098261)
10. Heesch CM, Wilhelm CR, Ristich J et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 83(6), 688-695 (2000). (Pubitemid 30345974)
11. Yao H, Duan M and Buch S. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 117(8), 2538-2547 (2011).
12. Yao H, Kim K, Duan M et al. Cocaine hijacks sigma-1 receptor to initiate induction of ALCAM: implication for increased monocyte adhesion and migration in the central nervous system. J. Neuroscience 31(16), 5942-5955 (2011).
13. Kass MD, Liu X, Vigorito M et al. Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats. J. Neuroimmune Pharmacol. 5(4), 566-573 (2010).
14. Kiyatkin EA, Sharma HS. Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. Int. Rev. Neurobiol. 88, 65-100 (2009).
15. Revel FG, Moreau JL, Gainetdinov RR et al. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc. Natl Acad. Sci. USA 108(20), 8485-8490 (2011).
16. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186(2), S193-S198 (2002). (Pubitemid 35370481)
17. Roy S, Ninkovic J, Banerjee S et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J. Neuroimmune Pharmacol. 6(4), 442-465 (2011).
18. Dutta R, Roy S. Mechanism(s) involved in opioid drug abuse modulation of HAND. Curr. HIV Res. 10(5), 469-477 (2012).
19. Chang SL, Patel NA, Romero AA. Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration. Brain Res. 679, 89-98 (1995).
20. Ocasio FM, Jiang Y, House SD et al. Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock. J. Neurol. 149, 90-100 (2004). (Pubitemid 38352862)
21. Chang SL, Beltran JA, Swarup S. Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J. Virol. 81(16), 8406-8411 (2007). (Pubitemid 47242814)
22. Chang SL, Connaghan KP. Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J. Neuroimmune Pharmacol. 7(2), 332-340 (2012).
23. Chen SL, Tao PL, Chu CH et al. Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J. Neuroimmune Pharmacol. 7(2), 444-453 (2012).
24. Saiyed ZM, Gandhi NH, Nair MP. AZT 5́-triphosphate nanoformulation suppresses Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells. J. Neurovirol. 15(4), 343-347 (2009).
25. Saiyed ZM, Gandhi NH, Nair MPN. Magnetic nanoformulation of Azidothymidine 5́-triphosphate for targeted delivery across the blood-brain barrier. Int. J. Nanomed. 5, 157-166 (2010).
26. Anderson E, Zink W, Xiong H et al. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune Defic. Syndr. 31(Suppl. 2), S43-S54 (2002). (Pubitemid 35190558)
27. Chang L, Ernst T, Strickland T et al. Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. Am. J. Psychiatry 156(5), 716-722 (1999). (Pubitemid 29220069)
28. United Nations Office of Drugs and Crime (UNODC), World Drug Report 2012 (United Nations publication, sales no. E.12. XI.1) 2012. www.unodc.org/ documents/data-and-analysis/WDR2012/WDR-2012-web-small.pdf (Accessed 1 November 2012)
29. Department of Health and Human Services. http://grants.nih.gov/grants/ guide/pa-files/ PA-11-014.html (Accessed 1 November 2012)